Bottom line
Is MTRAX a good fund? The bottom line
MTRAX is the Class A share class of NYLI Income Builder Fund, an actively managed allocation / balanced mutual fund from MFS.
It charges 1.02% — about $102 a year on every $10,000 invested, more expensive than 61% of allocation / balanced funds we track.
It returned +13.2% over one year, +5.6% a year over five years, +6.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.2 billion in net assets and 644 holdings, its largest position is United States of America (2.6%) and the top 10 make up 14.7% of the portfolio.
This share class carries a front-end sales charge of up to 3%; a no-load class or ETF alternative can avoid it.
What stands out
- Broadly diversified (644 holdings)
What to watch
- Front-end sales load up to 3%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MTRAX invests in
The Fund seeks current income consistent with reasonable opportunity for future growth of capital and income.
"The Fund normally invests a minimum of 30% of its net assets in equity securities and a minimum of 30% of its net assets in debt securities. From time to time, the Fund may temporarily invest less than 30% of its net assets in equity or debt securities as a result of market conditions, individual securities transactions or cash flow considerations. Asset Allocation Investment Process : Asset allocation decisions are made by a Committee chaired by New York Life Investment Management, the Funds Manager, in collaboration with MacKay Shields LLC (MacKay Shields), the subadvisor for the fixed-income portion of the Fund. Asset allocation decisions are determined based on the relative values of each asset class, inclusive of the ability of each asset class to generate income. The Fund may use equity index and fixed-income futures to manage effective exposure, for example, by adding exposure…
From the fund's prospectus (filed Feb 26, 2026).
MTRAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MTRAX | +13.2% | +5.6% | +6.4% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What MTRAX costs
On a $10,000 investment, MTRAX's 1.02% expense ratio costs about $102 a year. The prospectus estimates $1,510 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
MTRAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | United States of America | 2.62% |
| 2 | United States of America | 1.60% |
| 3 | Hewlett Packard Enterprise Co. | 1.44% |
| 4 | Microsoft Corp. | 1.41% |
| 5 | Cisco Systems, Inc. | 1.37% |
| 6 | Dell Technologies, Inc. | 1.32% |
| 7 | CVS Health Corp. | 1.29% |
| 8 | Taiwan Semiconductor Manufacturing Co. Ltd. | 1.29% |
| 9 | Broadcom, Inc. | 1.27% |
| 10 | Texas Instruments, Inc. | 1.14% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 14.7% of the fund. See all top 25 holdings and asset mix →